European markets close higher ahead of Christmas shutdown; Novo Nordisk resumes recovery

European markets minuscule higher on Tuesday, in a shortened trading day for Christmas Eve.

The pan-European Stoxx 600 provisionally ended the session around 0.2% prodigal. Tech stocks were among those leading the gains, following a strong trading session on Monday for U.S.-listed technology parts.

London’s FTSE 100 and the French CAC 40 index both ended the session in positive territory, with sectors across the eat seeing gains ahead of the Christmas shutdown.

Novo Nordisk resumed its mobilize on Tuesday, rising to the top of the Stoxx 600 and adding 5.7% by the closing bell. Shares of the Danish pharmaceuticals giant were repossessing from last week’s major sell-off, which followed disappointing results from the trial of its CagriSema worth loss drug.

Elsewhere in European pharmaceuticals, AstraZeneca said Tuesday it had voluntarily withdrawn its EU marketing application for its datopotamab deruxtecan lung cancer treatment. The companions said the decision, made alongside co-developer Daiichi Sankyo, “was informed by feedback from the Committee for Medicinal Results for Human Use of the European Medicines Agency.”

Back in September, disappointing results from the clinical trial on which the practice was based dented AstraZeneca’s share price. Shares of the company were up 0.1% at the end of the Christmas Eve session.

In other point news, Anglo American is facing legal issues in Chile after the country’s Superintendency of the Environment (SMA) filed four environmental wardships against the company on Monday. The firm could face a fine of up to $17 billion over alleged non-compliance with environmental permits at its Los Bronces copper dig, according to a Google translation of the SMA statement.

In an emailed statement, an Anglo American spokesperson said the mine was operating normally and that the flock was working with the Chilean regulator to ensure compliance.

The mining giant’s London-listed shares closed up 2%. Mining staples led the gains on the Stoxx 600 on Tuesday, after news agency Reuters reported China was planning to issue a information 3 trillion yuan ($411 billion) worth of treasury bonds in 2025.

At the bottom of the Stoxx 600 was British homebuilder Vistry Catalogue, whose shares plummeted 16% throughout the course of Tuesday’s session.

The company revised its full-year guidance on Tuesday, trimming £50 million from its profit outlook. Vistry said it now expects its full-year adjusted profit before tax to finish in the money b be in at around £250 million, attributing the downward revision to delays to expected year-end transactions and completions.

Shares of Swedish online take a chancing firm Evolution continued their selloff on Tuesday, after tumbling to the bottom of the European index on Monday. Definitive week, the company said it had been placed under review by the U.K. Gambling Commission, after the regulator discovered the plc’s games were accessible in Britain through unlicensed operators.

Overnight in Asia, stocks were in mixed quarter as investors monitored the monetary policy outlook in Japan, the blockbuster merger between autos giants Honda and Nissan and faltering consumer certitude in South Korea.